Clene Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value
Clene Inc. (CLNN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $95.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-24.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2025-03-24
- Clene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-12-31 was $30.00K.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2024-09-30 was $16.00K.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-12-31 was -$1.73M.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for the quarter ending 2022-09-30 was $293.00K.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $95.00K.
- Clene Inc. share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $915.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month |
|---|---|---|---|---|
| 2024-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $46.00K derived: sum of 2 quarters · filed 2025-03-24 | $95.00K 10-K · filed 2025-03-24 | |
| 2024-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $65.00K 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | $49.00K 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$1.43M derived: sum of 2 quarters · filed 2023-03-13 | $915.00K 10-K · filed 2023-03-13 | |
| 2022-09-30 | $293.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.64M 10-Q · filed 2022-11-07 | ||
| 2022-06-30 | $2.35M 10-Q · filed 2022-08-15 | |||
| 2021-06-30 | $1.84M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |